Catheter having a funnel-shaped occlusion balloon of uniformthickness and methods of manufacture
Abstract
Methods and apparatus are provided for removing emboli during an angioplasty, stenting or surgical procedure comprising a catheter having a funnel--shaped occlusion balloon of uniform thickness disposed on a distal end of the catheter. The occlusion balloon is fused to the distal end so that it provides a substantially seamless flow transition into a working lumen of the catheter. Additionally, a distal edge of the occlusion balloon is configured to be in close proximity with an inner wall of a vessel to facilitate blood flow into the catheter and efficiently remove emboli.

Term
Term ended
Expired 25 June 2023, 3.2 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
24 claims: 2 independent, 22 dependent
- 1CA 02492020 2007-05-03 What is claimed is:1. Apparatus for removing emboli from a vessel during an interventional procedure, the apparatus comprising: a catheter having proximal and distal ends, a working lumen extending therethrough, to define an interior surface, and an exterior surface;and an occlusion balloon having a distal end affixed to the exterior surface of the catheter adjacent the distal end of the catheter and a proximal end everted to surround, and affixed to, the exterior surface of the catheter at a location proximal of the distal end of the catheter, the occlusion balloon having a contracted state suitable for insertion into a vessel and a deployed state configured to occlude antegrade flow in the vessel, the occlusion balloon having a substantially rhomboidal shape in the deployed state, wherein the occlusion balloon consists of a single sheet of elastomeric having a substantially uniform wall thickness, and in the deployed state, provides a funnel-shaped surface that extends beyond the distal end of the catheter, a portion of the distal end of the occlusion element also affixed to the interior surface of the catheter to provide a seamless transition into the working lumen.
- 14Apparatus for removing emboli from a vessel during an interventional procedure, the apparatus comprising:a catheter having proximal and distal ends, a working lumen extending therethrough, the catheter comprising an interior polymer cover defining the working lumen, an exterior polymer cover, and a wire braid disposed between the interior polymer cover and the exterior polymer cover: CA 02492020 2007-05-03 a radiopaque marker band disposed at the distal end of the catheter between the wire braid and the exterior polymer cover;and an occlusion balloon having a distal end affixed to the exterior polymer cover and a proximal end everted to surround, and affixed to the exterior polymer cover at a location proximal of the distal end of the catheter, the occlusion balloon having a contracted state suitable for insertion into a vessel and a deployed state configured to occlude antegrade flow in the vessel, wherein the occlusion balloon comprises an elastomeric material having a substantially uniform wall thickness, and in the deployed state, provides a funnel-shaped surface, the distal end of the occlusion balloon also affixed to the interior polymer cover to form a seamless transition into the working lumen.
Independent claims2
71 paragraphs in 23 sections, as filed
CA 02492020 2004-12-29
WO 2004/002564
PCT/US2003/019764
CATHETER HAVING A FUNNEL-SHAPED OCCLUSION BALLOON OF UNIFORM THICKNESS AND METHODS OF MANUFACTURE
Field Of The Invention
[0001] This invention relates to apparatus and methods 5 for removing emboli during vascular interventions. More particularly, the apparatus and methods of the present invention provide a catheter having an occlusion balloon of uniform thickness that facilitates retrograde flow and removes emboli from a treatment vessel via a funnel10 shaped taper of the occlusion balloon.
Background of the Invention
[0002] Today there is a growing need to provide controlled access and vessel management during such procedures as stenting, atherectomy and angioplasty. Generally during these procedures there is a high opportunity for the release of embolic material. The emboli may travel downstream from the occlusion, lodging deep within the vascular bed and causing ischemia. The resulting ischemia may pose a serious threat to the health or life of a patient if the blockage forms in a critical area, such as the heart, lungs, or brain.
CA 02492020 2007-05-03
U Ο 20ι·4 ίΐϋ
PCT ( S3i»((5/Ot*/ <»4
[0003] Several previously known apparatus and methods attempt to remove emboli formed during endovascular procedures by aspirating the emboli out of the vessel of interest using a catheter having an occlusion balloon.
These previously known occlusion balloons, however, have various drawbacks, including variability in deployment of the balloon to the desired shape, inefficiency in removing emboli, and/or high cost and complicated processes associated with manufacturing the balloon.
[0004] In applicant's co-pending U.S. patent
No. 6,423,032, filed October 15, 1999, issued July 23, 2002, applicant describes the use of a bell or pearshaped occlusion balloon disposed on the distal end of an 15 arterial catheter. The occlusion balloon comprises a compliant material having a variable thickness along its length to provide a bell-shape when inflated. The balloon is affixed to distal end of the catheter so that a distal portion of the balloon extends beyond the distal end of the catheter to provide an atraumatic tip or bumper for the catheter.
[0005] The balloon of that catheter may be formed using previously known techniques, such as varying the thickness of the balloon wall to achieve the preferred bell-shape in the deployed position. Such processes, however, can lead to variability in the final product due to the manufacturing process. Because variable thickness balloons present greater difficulties during manufacture than balloons having uniform wall thickness, the cost of such balloons may be higher.
[0006] In view of the foregoing limitations of previously known devices, it would be desirable to provide an apparatus for removing emboli from a vessel
CA 02492020 2004-12-29
WO 2004/002564
PCT/US2003/019764
- 3 comprising an occlusion balloon of uniform thickness to enhance manufacturability of the occlusion balloon.
[0007] It also would be desirable to provide an apparatus for removing emboli from a vessel comprising an occlusion balloon of uniform thickness to reduce manufacturing cost and enhance product yield.
[0008] It further would be desirable to provide an apparatus for removing emboli from a vessel comprising a catheter having an occlusion balloon of uniform thickness that facilitates retrograde flow and efficiently removes emboli .
Summary of the Invention
[0009] In view of the foregoing, it is an object of 15 this invention to provide an apparatus for removing emboli from a vessel comprising an occlusion balloon of uniform thickness to enhance manufacturability of the occlusion balloon.
[0010] It also is an object of the present invention 20 to provide an apparatus for removing emboli from a vessel comprising an occlusion balloon of uniform thickness to reduce manufacturing cost and enhance product yield.
[0011] It further is an object of the present invention to provide an apparatus for removing emboli from a vessel comprising a catheter having an occlusion balloon of uniform thickness that facilitates retrograde flow and efficiently removes emboli.
[0012] The foregoing objects of the present invention are accomplished by providing interventional apparatus comprising a catheter having proximal and distal ends, a working lumen extending therethrough and an occlusion balloon having proximal and distal ends disposed on the distal end of the catheter. The occlusion balloon has a
CA 02492020 2004-12-29
WO 2004/002564 PCT/US2003/019764
- 4 contracted state suitable for insertion into a vessel and a deployed state configured to occlude antegrade flow in the vessel.
[0013] In a preferred embodiment, the catheter 5 comprises an inner layer covered with a layer of flat stainless steel wire braid and a polymer cover. A distal section of the occlusion balloon is melt-bonded to a distalmost end of the inner layer and, optionally, to a distalmost end of the polymer cover to form a substantially seamless transition into the working lumen of the catheter. The proximal end of the occlusion balloon is everted and affixed to the polymer cover to form an inflation chamber between the polymer cover and the balloon.
[0014] In the deployed state, the occlusion balloon is configured to extend distal of the catheter and provides a funnel-shaped transition into the working lumen of the catheter. A distal edge of the occlusion balloon is configured to be in close proximity with an inner wall of a vessel to facilitate retrograde flow into the working lumen of the catheter and efficiently remove emboli. Additionally, because the occlusion balloon of the present invention comprises a uniform thickness, the balloon may be more reliable, easier to manufacture and more cost-effective than an occlusion balloon having a variable thickness along its length.
[0015] Preferred methods of making and using the apparatus of the present invention also are disclosed.
Brief Description of the Drawings
[0016] Further features of the invention, its nature and various advantages will be more apparent from the
CA 02492020 2007-05-03
PC Ï LsZocS/it ίν~ο4
- H — accompanying drawings and the following detailed description of the preferred embodiments, in which:
[0017] FIGS. ±.A-1E are, respectively, side and sectional views of a previously known, occlusion balloon in contracted and deployed states;
[0018] FIGS. 2A-23 are, respectively, a schematic view of apparatus in accordance with the present invention and a cross-sectional view along line A--A of FIG. 2A;
[0015] FIGS. 3A-3B are side sectional views illustrating a preferred configuration of the distal end of the catheter of FIG. 2;
[0020] FIGS. 4A-4B are side sectional views of the occlusion balloon of the present invention in contracted and deployed states, respectively; and
[0021] FIG. 5 is a schematic view of apparatus of the present invention being used during an interventional procedure.
Description of the Preferred Embodiments
[0022] Referring to FIGS. 1A-1B, a bell-shaped occlusion balloon, as described in applicant's commonly assigned U.S. Patent No. 6,423,032 is described. Occlusion balloon 20 is shown in contracted and deployed states in FIGS. 1A and IB, respectively. Balloon 20 is affixed to distal end 26 of catheter 22, for example, by gluing or a melt-bond, so that opening 27 in balloon 20 leads into lumen 28 of catheter 22. Balloon 20 preferably is wrapped and heat treated during manufacture so that distal portion 29 of the balloon extends beyond the distal end of catheter 22 and provides an atraumatic tip or bumper for the
CA 02492020 2004-12-29
WO 2004/002564
PCT/US2003/019764 catheter. In accordance with manufacturing techniques which are known in the art, occlusion balloon 20 comprises a compliant material, such as polyurethane, latex or polyisoprene which has variable thickness along its length to provide a bell-shape when inflated.
[0023] As described hereinabove, the variable thickness characteristic of occlusion balloon 20, which is used to deploy the balloon to the preferred bellshape, presents certain manufacturing challenges. In particular, manufacturing a balloon having a variable wall thickness can lead to reduced yield due to variability of the manufacturing process. Additionally, a variable thickness balloon may be difficult to manufacture and may have a higher cost relative to a balloon having a uniform thickness.
[0024] Referring now to FIGS. 2, a first embodiment of apparatus constructed in accordance with principles of the present invention is described. Apparatus 40 comprises catheter 41 having proximal and distal ends and working lumen 58 extending therethrough. Catheter 41 comprises occlusion balloon 42 having proximal and distal ends affixed to the distal end of catheter 41, and preferably comprises radiopaque marker band 65 disposed at the distal end of catheter 41 to facilitate positioning of the distal end of the catheter.
[0025] Occlusion balloon 42 comprises a uniform thickness material having a contracted state suitable for insertion into a vessel and a deployed state in which occlusion balloon 42 occludes antegrade flow in the vessel. In the deployed state, occlusion balloon 42 comprises distal taper 66 that is configured to provide a funnel-shaped transition into working lumen 58 so that blood flows in a non-turbulent fashion from a treated
CA 02492020 2004-12-29
WO 2004/002564 PCT/US2003/019764
- 7 vessel into catheter 41. Additionally, distal edge 68 is configured to be in close proximity with an inner wall of a vessel to facilitate blood flow into catheter 41 and efficiently remove emboli.
[0026] Catheter 41 preferably comprises inner layer 60 of low-friction polymeric material, such as polytetrafluoroethylene (PTFE), covered with a layer of flat stainless steel wire braid 61 and polymer cover 62 (e.g., polyurethane, polyethylene, or PEBAX), as shown in
FIG. 2B. Working lumen 58 is defined as a lumen within an interior surface of inner layer 60. Inflation lumen 63 preferably is disposed within polymer cover 62 so that the inflation lumen does not substantially increase the overall profile of catheter 41.
[0027] Apparatus 40 preferably further includes proximal hemostatic port 43, e.g., a Touhy-Borst connector, inflation port 44, and blood outlet port 48. Inflation port 44 is coupled to inflation lumen 63, which in turn is coupled to occlusion balloon 42. Proximal hemostatic port 43 and working lumen 58 of catheter 41 are sized to permit interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through the working lumen when a guidewire (not shown) is positioned within the working lumen.
[0028] Blood outlet port 48, which is in fluid communication with working lumen 58, may be coupled to an external aspiration device, e.g., a syringe, to cause blood flow distal of occlusion balloon 42 to flow into working lumen 58. Alternatively, in a preferred embodiment, blood outlet port 48 may be coupled to a venous return catheter to form an arterial-venous shunt suitable for providing retrograde flow in a treatment
CA 02492020 2007-05-03
2»,U 0015(4
F*C Γ Λ (I l‘J764 vessel. This aspiration embodiment comprising an arterial-venous shunt is described in detail in applicant's commonly-assigned U.S. Patent No. 6,423,032.
[0029] Referring now to FIGS. 3, a preferred configuration of catheter 41 and a preferred method for affixing occlusion balloon 42 to the distal end of catheter 41 are described. In FIG. 3A, the distal end of catheter 41 is shown from a side sectional view as comprising inner layer 60 covered with a layer of flat stainless steel wire braid 61 and polymer cover 62.
Radiopaque marker band 65 preferably is disposed at the distal end of catheter 41 between wire braid 61 and polymer cover 62, as shown in FIG. 3A. In accordance with principles of the present invention, occlusion balloon 42 comprises a uniform thickness along its length, as illustrated in FIGS. 3A-3B.
[0030] In a preferred method of manufacture, distal end 50 of occlusion balloon 42 is positioned atop polymer cover 62 near the distal end of catheter 41 and just distal of opening 70 of polymer cover 62, as shown in FIG. 3A. Distal end 50 of occlusion balloon 42 then is affixed to polymer cover 62, preferably using a melt-bond or, alternatively, using a biocompatible glue. At this time, proximal end 52 of occlusion balloon 42 extends freely beyond the distal end of catheter 41, as shown in FIG. 3A. For purposes of clarifying terminology used herein, although proximal end 52 of occlusion balloon 42 appears situated distal of distal end 50 in FIG. 3A, this is because proximal end 52 will subsequently be everted to extend proximal of distal end 50, as described hereinbelow.
CA 02492020 2004-12-29
WO 2004/002564 PCT/US2003/019764
- 9 [0031] In a next manufacturing step, distal section 51 of occlusion balloon 42, which is situated just proximal of distal end 50, is melt-bonded to at least one polymeric layer of catheter 41. Specifically, in a preferred embodiment, distal section 51 of occlusion balloon 42 is melt-bonded to distalmost end 85 of inner layer 60 and, optionally, to distalmost end 87 of polymer cover 62 to form fusion joint 67, as shown in FIG. 3A.
The melt-bonding of the plurality of polymeric materials at fusion joint 67 provides substantially seamless transition 72 between occlusion balloon 42 and inner layer 60. Additionally, because fusion joint 67 is formed from a plurality of compliant polymeric materials, fusion joint 67 is capable of achieving a flexible range of motion.
[0032] Proximal end 52 of occlusion balloon 42 then is everted so that it extends proximally and radially outward from catheter 41, as shown in FIGS. 3B and 4A. Proximal end 52 is affixed to polymer cover 62, preferably using a melt-bond or, alternatively, using a biocompatible glue, at a distance between about 10-20 mm proximal of the distal end of catheter 41, as shown in FIG. 4A. This creates inflation chamber 74 between polymer cover 62 and an interior surface of balloon 42.
Opening 70, which is disposed in a lateral surface of polymer cover 62, is in fluid communication with inflation lumen 63 and inflation chamber 74, as shown in FIG. 3B. Proximal end 52 of occlusion balloon 42 may be stretched while it being affixed to polymer cover 62 so that apparatus 40 may achieve a reduced profile in the contracted state.
[0033] The fusion of occlusion balloon 42 to catheter at fusion joint 67 and subsequent eversion of the
CA 02492020 2004-12-29
WO 2004/002564 PCT/US2003/019764
- 10 balloon creates substantially seamless transition 72 into working lumen 58, as shown in FIG. 3B. In accordance with principles of the present invention, the provision of substantially seamless transition 72 may help reduce flow impedance into working lumen 58 and enhance flow within a treated vessel.
[0034] Referring now to FIGS. 4A-4B, deployment of apparatus 40 within vessel V of a patient is described.
In FIG. 4A, occlusion balloon 42 is shown in a contracted state suitable for percutaneous and transluminal insertion into a patient's vessel. Occlusion balloon 42 is inflated via inflation port 44, inflation lumen 63 and opening 70, and deploys to a predetermined configuration having proximal taper 64 and distal taper 66, as shown in
FIG. 4B. The predetermined configuration may be determined, for example, using a pre-molding process in accordance with manufacturing techniques that are known in the art. In the deployed state, an outer surface of central section 75, which is formed between proximal and distal tapers 64 and 66, is substantially flush with an inner wall of vessel V. As will be understood by those skilled in the art, the expanded diameter of central section 75 may be sized accordingly for different vessels .
[0035] Distal edge 68 is defined as a section of occlusion balloon 42 that is formed between central section 75 and distal taper 66. In the deployed state, distal edge 68 is configured to be in close proximity with an inner wall of vessel V to facilitate blood flow into working lumen 58 and efficiently remove emboli.
[0036] Distal taper 66 provides a funnel-shaped flow transition from distal edge 68 into working lumen 58.
Additionally, as described hereinabove, fusion joint 67
CA 02492020 2004-12-29
WO 2004/002564 PCT/US2003/019764
- 11 provides substantially seamless transition 72 from occlusion balloon 42 into working lumen 58 due to the melt-bond between balloon 42 and inner layer 60 of catheter 41.
[0037] Referring now to FIG. 5, a preferred method for using apparatus 40 of FIG. 2A during an interventional procedure, such as balloon angioplasty, is described. In a first step, guidewire 83 is inserted into a patient's vasculature and a distal end of guidewire 83 is disposed just proximal of stenosis S, which is located in vessel V. A dilator (not shown) that is disposed within catheter 41 then is inserted over guidewire 83 to advance catheter 41 to a desired position proximal of stenosis S. When catheter 41 is properly positioned, e.g., as determined under fluoroscopy using radiopaque marker band 65, the dilator may be removed. Occlusion balloon 42 then is inflated via inflation port 44 of FIG. 2A, preferably using a radiopaque contrast solution, to occlude antegrade flow in vessel V. Aspiration is provided through working lumen 58 of catheter 41 to cause retrograde flow to occur in vessel V distal of occlusion balloon 42, as illustrated by the arrows in FIG. 5.
[0038] Aspiration may be provided through working lumen 58 via blood outlet port 48 using an external aspiration device, e.g., a syringe, or alternatively using a venous return catheter to form an arterial-venous shunt, as described hereinabove.
[0039] An interventional instrument, such as conventional angioplasty balloon catheter 80 having balloon 82, may be loaded through hemostatic port 43 and working lumen 58 and positioned within stenosis S, preferably via guidewire 83. Hemostatic port 43 is closed and the angioplasty balloon is actuated to disrupt
CA 02492020 2004-12-29
WO 2004/002564 PCT/US2003/019764
- 12 stenosis S. As seen in FIG. 5, emboli E formed during the interventional procedure are directed into working lumen 58 via the retrograde flow established.
[0040] Occlusion balloon 42 provides a substantially 5 uniform funnel-shaped transition from an inner wall of vessel V into working lumen 58 of catheter 41. Distal edge 68, which is configured to be in close proximity with an inner wall of vessel V, facilitates flow into working lumen 58 and efficiently removes emboli.
Additionally, the funnel-shaped transition provided by distal taper 66 and substantially seamless transition 72 into the working lumen via fusion joint 67 improves retrograde flow dynamics into working lumen 58.
[0041] Advantageously, because the present invention utilizes an occlusion balloon having a uniform thickness and relies on pre-molding of the occlusion balloon to obtain the desired deployed shape, a variable thickness occlusion balloon is not required. As noted hereinabove, use of an occlusion balloon having a uniform thickness provides several advantages, including enhanced manufacture, reduced cost and increased reliability.
[0042] While preferred illustrative embodiments of the invention are described above, it will be apparent to one skilled in the art that various changes and modifications may be made. The appended claims are intended to cover all such changes and modifications that fall within the true spirit and scope of the invention.
Contents23
6 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6
102 members in 10 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 10187058 | United States of America | – | |
| 18705802 | United States of America | A | |
| 18705802 | United States of America | A | |
| 0319764 | United States of America | W | |
| 0319764 | United States of America | W | |
| 10187058 | – | – | – |
| PCTUS03019764 | – | – | – |
| US20020187058 | – | – | – |
| WO2003US19764 | – | – | – |
Members102
| Document | Office | Kind | |
|---|---|---|---|
| WO9945835A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3084599A | Australia | A | |
| WO9945835A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2380350A1 | Canada | A1 | |
| CA2721188A1 | Canada | A1 | |
| WO0076390A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1061846A2 | European Patent Office (EPO) | A2 | |
| AU5738900A | Australia | A | |
| US6206868B1 | United States of America | B1 | |
| AR017498A1 | Argentina | A1 | |
| US2001044598A1 | United States of America | A1 | |
| WO0076390A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2002022859A1 | United States of America | A1 | |
| WO0232495A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1535702A | Australia | A | |
| EP1210142A2 | European Patent Office (EPO) | A2 | |
| US6413235B1 | United States of America | B1 | |
| US2002087119A1 | United States of America | A1 | |
| US6423032B2 | United States of America | B2 | |
| US2002107479A1 | United States of America | A1 | |
| US2002151922A1 | United States of America | A1 | |
| US2002173815A1 | United States of America | A1 | |
| US2003023204A1 | United States of America | A1 | |
| WO03008015A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03009880A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US6540712B1 | United States of America | B1 | |
| US6582396B1 | United States of America | B1 | |
| JP2003521286A | Japan | A | |
| WO03077983A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003224695A1 | Australia | A1 | |
| US6632236B2 | United States of America | B2 | |
| US6645222B1 | United States of America | B1 | |
| CA2492020A1 | Canada | A1 | |
| WO2004002564A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003280061A1 | Australia | A1 | |
| US6682505B2 | United States of America | B2 | |
| WO03008015A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03009880A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03009880A9 | World Intellectual Property Organization (WIPO) | A9 | |
| EP1416993A2 | European Patent Office (EPO) | A2 | |
| EP1427460A2 | European Patent Office (EPO) | A2 | |
| JP2004535253A | Japan | A | |
| JP2004535889A | Japan | A | |
| EP1061846A4 | European Patent Office (EPO) | A4 | |
| AU781760B2 | Australia | B2 | |
| US6905490B2 | United States of America | B2 | |
| US2005131453A1 | United States of America | A1 | |
| US6908474B2 | United States of America | B2 | |
| EP1545685A1 | European Patent Office (EPO) | A1 | |
| AU2005202496A1 | Australia | A1 | |
| US6936060B2 | United States of America | B2 | |
| US2005228432A1 | United States of America | A1 | |
| US6960222B2 | United States of America | B2 | |
| EP1210142A4 | European Patent Office (EPO) | A4 | |
| US2006041228A1 | United States of America | A1 | |
| EP1545685A4 | European Patent Office (EPO) | A4 | |
| EP1427460A4 | European Patent Office (EPO) | A4 | |
| AU2003280061B2 | Australia | B2 | |
| AU2007200632A1 | Australia | A1 | |
| CA2492020CThis record | Canada | C | |
| AU2005202496B2 | Australia | B2 | |
| AU2008229661A1 | Australia | A1 | |
| JP2009172390A | Japan | A | |
| JP2009213914A | Japan | A | |
| EP1416993A4 | European Patent Office (EPO) | A4 | |
| EP1061846B1 | European Patent Office (EPO) | B1 | |
| AT459390T | Austria | T | |
| ATE459390T1 | Austria | T1 | |
| DE69942088D1 | Germany | D1 | |
| AU2007200632B2 | Australia | B2 | |
| ES2340559T3 | Spain | T3 | |
| AU2010202027A1 | Australia | A1 | |
| AU2010202028A1 | Australia | A1 | |
| US2010204724A1 | United States of America | A1 | |
| EP2236170A2 | European Patent Office (EPO) | A2 | |
| EP1545685B1 | European Patent Office (EPO) | B1 | |
| DE60335011D1 | Germany | D1 | |
| EP1210142B1 | European Patent Office (EPO) | B1 | |
| CA2380350C | Canada | C | |
| AT495785T | Austria | T | |
| ATE495785T1 | Austria | T1 | |
| DE60045555D1 | Germany | D1 | |
| US7927347B2 | United States of America | B2 | |
| EP2311519A1 | European Patent Office (EPO) | A1 | |
| ES2357758T3 | Spain | T3 | |
| JP2011087971A | Japan | A | |
| JP4704678B2 | Japan | B2 | |
| EP2335770A1 | European Patent Office (EPO) | A1 | |
| EP2236170A3 | European Patent Office (EPO) | A3 | |
| US2011160762A1 | United States of America | A1 | |
| AU2008229661B2 | Australia | B2 | |
| EP1427460B1 | European Patent Office (EPO) | B1 | |
| AT522236T | Austria | T | |
| ATE522236T1 | Austria | T1 | |
| ES2370388T3 | Spain | T3 | |
| AU2010202027B2 | Australia | B2 | |
| AU2010202028B2 | Australia | B2 | |
| JP4865825B2 | Japan | B2 | |
| EP2236170B1 | European Patent Office (EPO) | B1 | |
| ES2404842T3 | Spain | T3 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| LapsedLapsedMKLA | MKLA | |
| Examination requestEEER | EEER |
Numbers
- Publication
- 2492020
- Publication, DOCDB
- 2492020
- Publication, EPODOC
- CA2492020
- Application
- 2492020
- Application, DOCDB
- 2492020
- Application, EPODOC
- CA20032492020
Titles2
- English
- CATHETER HAVING A FUNNEL-SHAPED OCCLUSION BALLOON OF UNIFORM THICKNESS AND METHODS OF MANUFACTURE
- French
- CATHETER COMPRENANT UN BALLONNET D'OCCLUSION EN FORME D'ENTONNOIR D'EPAISSEUR UNIFORME ET PROCEDES DE FABRICATION CORRESPONDANTS
Classification
- CPC, 24
- A61B17/22
- A61B17/12
- A61B17/12045
- A61B17/12109
- A61B17/12136
- A61B17/12172
- A61B17/221
- A61B2017/00243
- A61B2017/22067
- A61B2017/2215
- A61B2217/005
- A61M25/10
- A61M25/1002
- A61M25/1027
- A61M25/1029
- A61M25/1034
- A61M25/104
- A61M2025/0175
- A61M2025/1015
- A61M2025/1031
- A61M2025/1065
- A61F2230/0006
- A61F2/011
- A61F2/014
- IPC, 8
- A61B17 22
- A61B17 12
- A61F2 01
- A61M25 10
- A61B17 00
- A61F2 958
- A61M1 00
- A61M25 00